Captrust Financial Advisors Blueprint Medicines Corp Transaction History

Captrust Financial Advisors

  • $34.2 Billion
  • Q4 2024

A detailed history of Captrust Financial Advisors transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Captrust Financial Advisors holds 8,331 shares of BPMC stock, worth $782,614. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,331
Previous 17,904 53.47%
Holding current value
$782,614
Previous $1.66 Million 56.13%
% of portfolio
0.0%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$82.48 - $101.39 $789,581 - $970,606
-9,573 Reduced 53.47%
8,331 $726,000
Q3 2024

Nov 14, 2024
BUY
$84.1 - $120.5 $48,946 - $70,131
582 Added 3.36%
17,904 $1.66 Million
Q2 2024

Aug 14, 2024
SELL
$85.18 - $108.78 $664,489 - $848,592
-7,801 Reduced 31.05%
17,322 $1.87 Million
Q1 2024

May 15, 2024
SELL
$73.17 - $99.79 $996,941 - $1.36 Million
-13,625 Reduced 35.16%
25,123 $2.38 Million
Q4 2023

Feb 14, 2024
SELL
$43.96 - $92.84 $559,171 - $1.18 Million
-12,720 Reduced 24.71%
38,748 $3.57 Million
Q3 2023

Nov 14, 2023
BUY
$46.9 - $66.0 $77,994 - $109,758
1,663 Added 3.34%
51,468 $2.58 Million
Q2 2023

Aug 14, 2023
BUY
$42.2 - $66.37 $937,979 - $1.48 Million
22,227 Added 80.6%
49,805 $3.15 Million
Q1 2023

May 15, 2023
BUY
$37.97 - $50.0 $315,758 - $415,800
8,316 Added 43.17%
27,578 $1.24 Million
Q4 2022

Feb 15, 2023
BUY
$41.06 - $66.48 $91,112 - $147,519
2,219 Added 13.02%
19,262 $843,000
Q3 2022

Nov 16, 2022
SELL
$49.93 - $77.7 $1,547 - $2,408
-31 Reduced 0.18%
17,043 $1.12 Million
Q2 2022

Aug 23, 2022
SELL
$45.23 - $70.15 $633 - $982
-14 Reduced 0.08%
17,074 $862,000
Q2 2022

Aug 16, 2022
BUY
$45.23 - $70.15 $39,892 - $61,872
882 Added 5.44%
17,088 $863,000
Q1 2022

May 16, 2022
BUY
$54.1 - $110.08 $21,694 - $44,142
401 Added 2.54%
16,206 $1.04 Million
Q4 2021

Feb 14, 2022
BUY
$94.25 - $115.99 $90,857 - $111,814
964 Added 6.5%
15,805 $1.69 Million
Q3 2021

Nov 16, 2021
BUY
$80.98 - $109.47 $202,692 - $274,003
2,503 Added 20.29%
14,841 $1.53 Million
Q1 2021

May 17, 2021
BUY
$90.71 - $108.28 $11,883 - $14,184
131 Added 1.07%
12,338 $1.2 Million
Q4 2020

Feb 16, 2021
SELL
$92.08 - $124.48 $62,061 - $83,899
-674 Reduced 5.23%
12,207 $1.37 Million
Q2 2020

Aug 14, 2020
BUY
$57.09 - $79.27 $91,344 - $126,832
1,600 Added 14.18%
12,881 $1.02 Million
Q1 2020

May 15, 2020
BUY
$48.11 - $82.22 $3,848 - $6,577
80 Added 0.71%
11,281 $644,000
Q4 2019

Feb 14, 2020
BUY
$66.73 - $82.59 $747,442 - $925,090
11,201 New
11,201 $921,000

Others Institutions Holding BPMC

# of Institutions
373
Shares Held
65.1M
Call Options Held
2.25M
Put Options Held
1.01M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.61B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email